Co-Diagnostics, Inc.

NASDAQ:CODX

1.21 (USD) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 0.1610.2533.5552.4570.1980.6021.4015.0945.02322.69920.40130.10127.35820.02527.14521.81924.041.5490.1090.0410.0620.0030.0110.010.010.010.0030.0030.002000000.01
Cost of Revenue 0.550.5653.2810.2560.4590.5020.5160.7680.9153.2822.4873.3112.5043.2734.3135.8218.3450.4820.0530.020.03900.009000000000000
Gross Profit -0.389-0.3120.2742.201-0.2610.10.8864.3274.10819.41717.91526.7924.85416.75222.83215.99715.6961.0670.0560.0210.0230.0030.0010.010.010.010.0030.0030.002000000.01
Gross Profit Ratio -2.417-1.2360.0770.896-1.3210.1660.6320.8490.8180.8550.8780.890.9080.8370.8410.7330.6530.6890.5140.5080.370.8670.132111110.878000001
Reseach & Development Expenses 5.6135.686.1795.7895.9815.0144.7395.0373.893.7712.1825.8934.6692.2171.1130.9220.750.40.3810.3310.3130.3470.3750.330.3580.2970.2810.2720.1850.2650.1920.1730.1720.1950.194
General & Administrative Expenses 3.1322.9194.4043.1483.7143.0145.253.6222.4682.9223.2272.9192.4682.9362.4252.2032.1911.4590.9881.0610.8080.640.691.150.8490.8821.0831.4060.3820.2260.1990.1830.1870.2270.204
Selling & Marketing Expenses 1.0411.5641.5171.9041.7331.7061.331.891.4722.6522.0944.2535.8531.1983.2080.7980.390.2680.2910.2620.2520.2560.7460.180.1440.0950.120.1170.1260.0640.0460.0290.0220.0250.048
SG&A 4.1744.4825.9215.0525.4474.726.585.5123.9415.5745.3217.1738.3224.1335.6333.0022.5811.7281.281.3231.060.8961.4361.330.9930.9771.2021.5230.5070.290.2450.2120.2090.2530.251
Other Expenses 0.1260.096-0.3570.04100.3160.2990.31200.2470.1030.0940.0720.0670.0570.0350.0250.0210.0190.0170.0160.0140.0130.0130.0130.0120.0130.0120.0110.010.0080.0070.0090.0130
Operating Expenses 9.78610.16212.111.13711.73310.0511.61910.8628.2559.5937.60613.1613.0636.4176.8033.9593.3572.1491.6791.6711.3891.2571.8251.6731.3631.2871.4961.8080.7030.5640.4450.3920.390.4610.459
Operating Income -10.176-10.475-11.825-8.936-11.994-9.9513.836-6.536-4.1476.53810.30913.6311.79110.33516.02912.03812.339-1.082-1.623-1.65-1.366-1.254-1.823-1.664-1.353-1.277-1.494-1.805-0.701-0.564-0.445-0.392-0.39-0.461-0.449
Operating Income Ratio -63.163-41.443-3.326-3.637-60.637-16.532.737-1.283-0.8260.2880.5050.4530.4310.5160.590.5520.513-0.699-14.953-39.824-22.181-368.968-168.461-171.593-139.58-131.748-574.938-694.788-284.24700000-44.94
Total Other Income Expenses Net 2.5971.1850.9830.5170.6451.935-28.883.060.6586.563-0.074-0.0650.129-0.465-0.2380.7490.2590.009-0.116-0.110.002-0.008-0.0410.068-0.025-0.04-0.015-2.074-0.154-0.141-0.081-0.058-0.052-0.05-0.035
Income Before Tax -7.579-9.289-10.842-8.096-11.157-8.015-25.044-3.476-3.42813.10110.24413.57711.939.88515.81212.81712.636-1.065-1.735-1.748-1.344-1.368-1.948-1.641-1.372-1.31-1.505-3.894-0.855-0.706-0.525-0.45-0.443-0.511-0.485
Income Before Tax Ratio -47.043-36.754-3.05-3.295-56.404-13.315-17.87-0.682-0.6820.5770.5020.4510.4360.4940.5830.5870.526-0.688-15.981-42.182-21.834-402.467-180.003-169.26-141.52-135.131-579.283-1,498.656-346.71800000-48.483
Income Tax Expense 0.0210.0233.834-2.114-2.238-2.26-3.139-2.115-0.7421.3862.7462.1012.1451.9863.005-2.9150.2590.009-0.116-0.110.0020.0980.0450.1170.019-0.04-0.0160.0150000000
Net Income -7.599-9.312-14.676-5.982-8.919-5.755-21.905-1.361-2.68611.7157.49811.4769.7857.89912.80715.73212.636-1.065-1.735-1.748-1.344-1.368-1.948-1.641-1.372-1.31-1.505-3.894-0.855-0.706-0.525-0.45-0.443-0.511-0.485
Net Income Ratio -47.171-36.844-4.128-2.435-45.089-9.561-15.63-0.267-0.5350.5160.3680.3810.3580.3940.4720.7210.526-0.688-15.981-42.182-21.834-402.467-180.003-169.26-141.52-135.131-579.283-1,498.656-346.71800000-48.483
EPS -0.25-0.31-0.47-0.2-0.31-0.2-0.71-0.044-0.0830.350.260.40.340.280.460.560.54-0.047-0.076-0.1-0.08-0.085-0.12-0.13-0.11-0.11-0.12-0.33-0.077-0.063-0.048-0.041-0.04-0.046-0.051
EPS Diluted -0.25-0.31-0.47-0.2-0.31-0.2-0.71-0.044-0.0830.340.250.380.330.260.460.530.51-0.047-0.076-0.1-0.079-0.085-0.12-0.13-0.11-0.11-0.12-0.33-0.077-0.063-0.048-0.04-0.04-0.046-0.051
EBITDA -9.837-10.144-11.512-9.203-12.46-11.094.134-9.113-4.4876.78510.41113.72411.86310.40215.8712.85212.661-1.044-1.716-1.731-1.328-1.249-1.849-1.58-1.316-1.298-1.494-1.793-0.69-0.555-0.437-0.385-0.381-0.447-0.436
EBITDA Ratio -61.063-40.135-3.238-3.745-62.99-18.4242.95-1.789-0.8930.2990.510.4560.4340.5190.5850.5890.527-0.674-15.805-41.771-21.572-367.395-170.835-162.92-135.691-133.852-574.953-690.009-279.75100000-43.561